Malvern Panalytical Biopharmaceutical and Drug Development

Characterisation technologies

Malvern Panalytical offers characterisation tools for molecular analysis and small drug discovery to help accelerate development for the pharmaceutical industry.

Malvern Panalytical provides characterisation technologies to the drug development industry that advance production processes by increasing productivity and yielding high-quality products at short time-to-market.

The company’s portfolio features a range of automated analysis tools and systems that provide information on key attributes such as particle size, shape, chemical identity, molecular weight, size, and concentration.

These reliable and robust characterisation techniques help drug development companies predict how a product will perform during use and allow for optimisation.

Systems for critical material attribute information

Malvern Panalytical has a wide range of experience in small molecule pharmaceuticals.

Services include systems that provide information on variables identified as critical material attributes (CMA) such as particle size, shape and chemical identity, or molecular weight and size.

Whether characterising particle size and morphological properties of a novel active pharmaceutical ingredient (API) or rheological attributes of a new chemical entity (NCE), Malvern Panalytical can achieve efficiency using common platform technologies.

Small molecule drug discovery and development

Malvern Panalytical’s range of analytical solutions focuses on testing and manufacturing requirements, while taking into account time and cost pressures, as well as sample availability and complexity.

Label-free technologies appeal to researchers across various applications, including biological research, biotherapeutic and small molecule drug discovery and development, immunogenicity studies, vaccine development and quality control.

Label-free techniques are used in the direct study of native molecules, and generate biologically relevant data enabling understanding of molecular interactions without using artificial probes or labels.

Isothermal titration calorimetry for biomolecular interactions

Malvern Panalytical’s MicroCal range includes isothermal titration calorimetry (ITC) and differential scanning calorimetry (DSC).

ITC is used in quantitative studies of a range of biomolecular interactions, that work by directly measuring heat that is either released or absorbed during a biomolecular binding event.

By providing a complete thermodynamic profile of the molecular interaction, ITC can explain mechanisms’ underlying interactions, and enable more confident decision-making in hit selection and lead optimisation.

DSC is used to characterise stability of a protein or other biomolecules directly in its native form, and achieves this by measuring heat change associated with the molecule’s thermal denaturation.

Precise and high-quality data obtained from DSC provides vital information on protein stability in process development, and in the formulation of potential therapeutic candidates.

Size exclusion chromatography systems for assessment of product purity

Malvern Panalytical’s analytical toolbox for biopharmaceutical development is tailored to provide trusted solutions such as OMNISEC size exclusion chromatography systems to assess product purity.

The Zetasizer range is also available for sizing and zeta potential analysis for product stability.

The company’s Archimedes and NanoSight systems quantify early aggregation in bioformulations.

About Malvern Panalytical

Malvern Panalytical’s technical experts are available to support and work with researchers to find the right solution for individual challenges.

Providing agile technology development in partnership with its Bioscience Development Initiative, Malvern Panalytical is always looking for new solutions to enable quicker, easier and more useful analysis.

The company has a suite of instruments that provides access to biophysical information focused on accelerating through characterisation studies, formulation development and quality control.

Malvern Panalytical provides high-quality products and helps clients to achieve maximum return from investment.

Make an enquiry

Press Release

Pharmaceutical Drug Development and Particle Sizing

Typically, when an individual is suffering from minor ailments at home, such as a headache, heartburn or a common cold, medications such as paracetamol, indigestion liquid and cold remedies are used in an attempt to alleviate symptoms. However, the reliability of these products can sometimes be questionable.

Malvern Panalytical Images

Products and Services

Video

White Papers

Related Projects



BESPONSA (inotuzumab ozogamicin) for the Treatment of Acute Lymphoblastic Leukaemia



BESPONSA® is an intravenous infusion indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).

17th May 2018

ADYNOVI for the Treatment of Adults and Adolescents with Haemophilia A



ADYNOVI® is an intravenous infusion indicated for the treatment of adults and adolescents with haemophilia A.

2nd May 2018

Hizentra for the Treatment of Patients with CIDP



Hizentra® (immune globulin subcutaneous 20% liquid) is a subcutaneous infusion indicated for the treatment of patients with chronic inflammatory demyelinating polyneuropathy (CIDP).

5th April 2018

Siklos (hydroxyurea) for the Treatment of Children with Sickle Cell Anaemia



Siklos® is an orally administered tablet form of hydroxyurea that is indicated for the treatment of sickle-cell anaemia in paediatric patients aged two years and older.

23rd March 2018

Zinbryta (daclizumab) for the Treatment of Multiple Sclerosis



Zinbryta (daclizumab) is an injectable formulation jointly developed by Biogen and Abbive for the treatment of relapsing forms of multiple sclerosis (MS) in adults.

22nd March 2018

Biktarvy for the Treatment of HIV-I



Biktarvy® is a once-daily regimen indicated for the treatment of HIV-1 infection in adults that were previously not treated with anti-retroviral medicines.

19th February 2018

Endari for the Treatment of Sickle Cell Disease



Endari™ is an orally administered powdered form of amino acid L-glutamine indicated for the treatment of sickle-cell disease.

25th January 2018

SUN-101/eFlow for the Treatment of Chronic Obstructive Pulmonary Disease



SUN-101 (Glycopyrrolate) is an inhalation solution developed by Sunovion Pharmaceuticals as a treatment for patients with moderate to severe chronic obstructive pulmonary disease (COPD).

18th August 2016

Epclusa (Sofosbuvir/ Velpatasvir) for the Treatment of Hepatitis C



Epclusa (Sofosbuvir/ Velpatasvir) is an oral formulation developed by Gilead Sciences for the treatment of 1-6 chronic hepatitis C virus (HCV) infection.

26th July 2016

Idelvion for the Treatment of Haemophilia B



Idelvion (Coagulation Factor IX (Recombinant), Albumin Fusion Protein) is an injectable formulation developed by CSL Behring, for the treatment of haemophilia B in children and adults.

13th June 2016

Press Release

13th August 2019

Typically, when an individual is suffering from minor ailments at home, such as a headache, heartburn or a common cold, medications such as paracetamol, indigestion liquid and cold remedies are used in an attempt to alleviate symptoms. However, the reliability of these products can sometimes be questionable.

Read more
8th July 2019

The New Model in Technology and Engineering (NMiTE) has announced three appointments to its Board of Trustees.

Read more
2nd July 2019

Malvern Panalytical has announced its next round of webinars. Find out more below. If you are interested in attending any of these events, please send an enquiry to find out how to register. 

Read more
24th May 2019

Malvern Panalytical has announced the next wave of webinars, seminars and conferences for June. 

Read more

Regional Offices

Malvern Canada

4995 Levy Street

Montreal

H4R 2N9

Quebec

Canada

+1 800 932 0101 +1 508 768 6403
Malvern Instruments China

Unit 101, XinAn Plaza

Building 13

No 99 Tianzhou Road

200233

Shanghai

China

+86 21 6113 3777 +86 4006 306 902 +86 4008 206 902 +86 8008 206 902 +86 21 6113 3778
Malvern Instruments Nordic

Korskildelund 6

DK-2670 Greve

Zealand

Denmark

+45 369 151 00 +45 369 151 01
Malvern Instruments Nordic

Kumitehtaankatu 5

Klondyke

Kerava

FIN-04260

Helsinki

Finland

+ 358 968 995 231 +358 968 995 232
Malvern Instruments SA

Parc Club de l'Université

30 Rue Jean Rostand

Orsay Cedex

91893

Ile-de-France

France

+33 169 351 800 +33 160 191 326 www.malvern.com/fr
Malvern Instruments GmbH

Marie-Curie-Str. 4/1

71083 Herrenberg

Germany

+49 703 297 770 +49 703 277 854 www.malvern.de
Malvern Aimil Instruments Pvt Ltd BSEL Tech Park

11th floor Sector - 30A Opp Vashi Railway Station

Vashi

Navi Mumbai

400 705

Mumbai

India

+91 22 3964 6600 +91 22 3964 6666
North Bldg 511 Kobe International Business Center

5-5-2 Minatojimaminami-machi Chuo-ku

Kobe-shi

Hyogo Prefecture

650-0047

Honshu

Japan

+81 78 306 3806 +81 78 306 3807 www.malvern.jp
Malvern Instruments Korea 7F SH Energy B/D

16-6 Sunae-Dong

Bundang-Gu, Seongnam-City

Kyeonggi-Do

Seoul

South Korea

+82 31 786 0840 +82 31 786 0950 www.malvern.co.kr
Malvern Instruments

Av. De La Industria No 300

San Pedro Garza Garcia

CP 66279

Nuevo Leon

Mexico

+52 5556 846 548
Malvern Instruments Nordic AB

Vallongatan 1

Uppsala

752 28

Uppsala County

Sweden

+46 185 52 455 +46 185 51 114
Malvern Instruments Inc

117 Flanders Road

Westborough

MA

01581-1042

Maine

United States of America

+1 508 768 6400 +1 508 768 6403
Close
Close
Close

Go Top